Halt Medical said today it won coverage for its Acessa System from Medicaid in Texas, Ohio, Michigan, Indiana and Washington D.C.
The Acessa system uses radiofrequency ablation guided by ultrasound to remove fibroids, which are benign, non-cancerous tumors that occur in women’s uteri, often during childbearing years, Brentwood, Calif.-based Halt Medical said.
The company said the coverage will be supplied under Category I CPT code 58674, which became effective Jan. 1 and covers laparoscopic surgical ablation of uterine fibroids including intraoperative ultrasound guidance and monitoring.
“Medicaid of Texas, Ohio, Michigan, Indiana, and D.C. join a growing list of leading-edge private insurers to provide coverage for the Acessa Procedure. These positive coverage decisions expand access to a population who may have otherwise been at risk for more invasive surgical procedures such as hysterectomy and myomectomy,” prez & CEO Kim Bridges said in a press release.
Last December, Halt Medical said that it won coverage from Blue Cross Blue Shield of South Carolina for procedures using its Acessa System to remove fibroids.
The company touted the reimbursement win, saying that BCBS covers nearly 1 million individuals and is the largest private insurer in South Carolina.
Halt Medical said that the American Medical Association recently granted a category 1 CPT code specifically for laparoscopic radiofrequency uterine fibroid ablation procedures, with the code going live on January 1st.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.